Founded by Mr. Veeresh Nalkal, Managing Director with over 15 years of global pharma marketing experience, Ayurzen Pharma Pvt. Ltd. has grown into a trusted partner for quality manufacturing, export, and innovation.
We collaborate with Samphra Synthesis Pvt. Ltd. (Vizag-based, WHO-GMP certified) and technology partner Zynlogic to merge manufacturing excellence with cutting-edge blockchain and Satellite IoT systems.
Ayurzen acts as a trusted integrator in the global pharmaceutical supply chain, managing every step from raw material sourcing to finished-product delivery. We combine deep technical expertise with international partnerships to provide comprehensive solutions. Key offerings include:
High-purity APIs from GMP-certified plants, exported worldwide.
Collaborations with global API manufacturers and CDMOs to scale supply and share innovation, ensuring all partners uphold rigorous quality standards.
Partnerships for sterile injectables, ophthalmics, and advanced nasal delivery systems in state-of-the-art, GMP-aligned facilities.
Assistance in converting APIs into finished products, including formulation development, dosage design, and bioequivalence studies, all under GMP protocols.
End-to-end guidance on regulatory filings (DMFs), GMP certification, and compliance documentation for both APIs and complex formulations.
Developing private/permissioned blockchain prototypes for immutable supply chain visibility is under research/pilot; not in production.
To deliver safe, affordable, and high-quality pharmaceutical products across the globe while integrating advanced technologies for transparency and sustainability.
To position Ayurzen Pharma as a global leader in pharmaceutical exports, driving innovation through blockchain and S-IoT, and strengthening India’s position as the pharmacy of the world.
Veeresh Nalkal, Chairman: A seasoned industry leader focused on quality and global reach, with experience across international markets. He promotes a culture of “quality and trust” and encourages research into secure supply chain technologies aligned with evolving global expectations.
Collaboration with Woxsen University integrates AI and pharmaceutical technology education, alongside exploratory research into blockchain-based traceability frameworks to secure supply chain data and enhance compliance readiness; all such work remains research/pilot and not production.
Adhering to WHO-GMP, ISO, and global regulatory norms.
Integrating Blockchain & Satellite IoT into pharma operations.
We enforce strict GMP and international quality standards at all stages, and we are pioneering blockchain-enabled tracking to further secure our supply chain.
End-to-end capabilities in APIs, sterile injectables, ophthalmics, and nasal delivery.
GMP compliance underpins every aspect of production, from facility selection to audits and release documentation, ensuring safety and regulatory alignment for international markets. Research into tamper-evident, immutable logging aligns conceptually with robust audit trails but is not currently in live use.
Any references to Blockchain or AI reflect ongoing research/pilot work and are not live production capabilities at this time.
